Trial intelligence / Profile preview

CoNteSSa: NACT and Fertility-Sparing Surgery in Cervical Cancer

NCT04016389Phase 2Recruiting

Sponsor
University Health Network
Start
Feb 2020
Primary completion
Dec 2026
Modality
DNA Intercalators/Alkylators
Countries
2
01

Overview

A Phase 2 trial of cisplatin, carboplatin, paclitaxel in Cervical Cancer (CC), sponsored by University Health Network. Started Feb 2020; status: recruiting.

02

Drugs

cisplatincarboplatinpaclitaxel
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT04016389.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04016389.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call